Aug 12, 2026 04:07PM
Aug 12, 2026 04:05PM
Nov 7, 2024 01:00AM
Aug 15, 2024 01:00AM
May 16, 2024 01:00AM
Feb 27, 2024 01:00AM
Nov 9, 2023 01:00AM Zealand Pharma Announces Financial Results for the First Nine Months of 2023
Aug 30, 2023 01:33AM
May 12, 2021 09:01AM
May 12, 2021 09:00AM
May 12, 2021 09:00AM
Nov 12, 2020 09:00AM
Nov 12, 2020 08:59AM
Aug 13, 2020 09:00AM Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal�
Aug 13, 2020 09:00AM
Jun 14, 2020 11:00AM
May 22, 2020 04:16PM
May 22, 2020 04:15PM
May 22, 2020 04:15PM
Nov 9, 2016 01:33AM
Aug 19, 2016 06:28PM Zealand announces new timelines for a U.S. FDA decision on iGlarLixi, the fixed-ratio combination of lixisenatide (AdlyxinTM) and Lantus(r), for the treatment of type 2 diabetes

15,690 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All